MYCOPLASMA TESTING MARKET

 

Market Overview:

               Over the projected period, 2022–2027, the mycoplasma testing market is anticipated to grow at a strong CAGR of 13%. The market for mycoplasma testing is also being driven by factors like high spending on R&D by biopharmaceutical companies, increased government initiatives and funding for research activities, technological advancements, rising demand for quick, accurate, and affordable testing, and rising cell culture contamination. According to a study published in October 2021 titled "Point-of-care molecular diagnosis of Mycoplasma pneumonia including macrolide sensitivity using quenching probe polymerase chain reaction," the Smart Gene system is a quick and reliable assay for simultaneously detecting the presence of M. pneumoniae and a point mutation at domain V of the 23S rRNA gene of M. pneumoniae.

Key Market Trends:

         The market for mycoplasma testing is now dominated by North America, and this dominance is anticipated to last for a few more years. Due to its well-established healthcare sector and the increased incidence of respiratory disorders there, this region is predicted to have a growth in market share in the future. The existence of multinational pharmaceutical and biotech companies as well as increased investment in R&D activities in the region are additional factors promoting the expansion of this region. In North America, the majority of the market is controlled by the United States. This is a result of increased healthcare costs and the quick uptake of point-of-care diagnostics.

The introduction of new products will also boost the number of mycoplasma testing procedures, which will support market expansion. For instance, in July 2020, bioMérieux introduced BIOFIRE MYCOPLASMA, a cutting-edge test for mycoplasma identification in the United States for pharmaceuticals used for biotherapeutics, the most dynamic segment of the pharmaceutical industry (antibodies, hormones, cell and gene treatments, etc.). Additionally, Infinity Laboratories increased its capabilities in April 2020 by starting to offer Mycoplasma testing. The leading market players' capabilities will be increased as a result of the adoption of crucial strategies including expansion, partnerships, acquisitions, and others, which will spur market expansion.

Comments

Popular posts from this blog

Shipping Containers Market Projected to Reach USD 12.77 Billion by 2030, Driven by E-commerce Growth and Cold-Chain Expansion

DATA CENTER POWER MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028)

Second Hand Furniture Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)